EC Number |
Inhibitors |
Structure |
---|
4.4.1.21 | (2S)-2-amino-4-[(2R,3R)-2,3-dihydroxy-3-N-hydroxycarbamoylpropylmercapto] butyric acid |
- |
|
4.4.1.21 | (2S)-2-amino-4-[(2R,3S)-2,3-dihydroxy-3-N-hydroxycarbamoylpropylmercapto] butyric acid |
- |
|
4.4.1.21 | (2S)-2-amino-6-(N-formyl-N-hydroxyamino)hexanoic acid |
- |
|
4.4.1.21 | Cu2+ |
1 mM, 6.1% of initial activity, respectively; 1 mM, 7.5% of initial activity, respectively |
|
4.4.1.21 | D-erythronohydroxamic acid |
- |
|
4.4.1.21 | D-ribosylornithine |
- |
|
4.4.1.21 | glycerol |
1 mM, 0.1% of initial activity, respectively; 1 mM, 8% of initial activity, respectively |
|
4.4.1.21 | methionine |
- |
|
4.4.1.21 | more |
5,6,7,8,9-pentadeoxy-6-fluoro-D-ribo-dec-5(Z)-enofuranuronate a S-ribosylhomocysteine analogue and 5,6-dideoxy-6-fluoro-D-ribo-hex-5-enofuranose a S-ribosylhomocysteine analogue have no inhibitory activity |
|
4.4.1.21 | Ni2+ |
1 mM, 23% of initial activity, respectively; 1 mM, 7.8% of initial activity, respectively |
|